GYRE
GYRE

Gyre Therapeutics Inc

NASDAQ · Biotechnology
$7.88
+0.37 (+4.93%)
Analyst Consensus
Strong Buy
9 analysts
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +279.7% upside
Low Target $20.05
Average Target $29.92
High Target $33.42
Current Price $7.88
Current
$7.88
Target
$29.92
$20.05 $29.92 avg $33.42